Targets › LINUP
1 program from 1 company in 3 trials: 2 Phase 2, 1 Phase 1; Infectious disease; next expected readout Feb 2027.
Open in Phaseline: the race on LINUP, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Sanaria | PfSPZ-LARC2 Vaccine Double deletion of MEI2 and LINUP genes in Plasmodium falciparum NF54 sporozoites - arrest | LINUP, MEI2 | Phase 2 | Malaria (Plasmodium Falciparum); Malaria Falciparum | Feb 2027 |
Malaria (Plasmodium Falciparum) (2) Malaria Falciparum (1)
mixed (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.